A new Hollywood film adaptation of The Odyssey is set to bring the ancient Greek epic poem to millions of people across the world on the big screen this summer. But while the film may spark fresh ...

Every frame of Christopher Nolan‘s “The Odyssey” was shot in Imax. But choosing a theater to watch the movie in is a little more complicated, since the epic film is coming to theaters in several ...

Christopher Nolan’s “The Odyssey” is living up to its name for moviegoers hoping to score tickets. On Thursday, trying to reserve seats for Imax and other premium screenings via the AMC ticketing app ...

Making plans to see Christopher Nolan’s “The Odyssey” turned into a quest of its own for some fans on Thursday as a surge of would-be ticket buyers appeared to bog down AMC’s website. Subscribe to ...

The Greek poet Homer sure knew how to tell a story. His 24-part epic The Odyssey has been regarded as a classic of literature going back to mid-6th century BC, and there have been countless ...

Cornerstone Companies Chief Operating Officer Glenn Fisher joins Shane and Kerrigan to share the hidden risks every employer should know. Junk King Kansas City Owner Jamie Kostelac joins Shane and ...

Westwood’s Village Theatre continues its revival: Universal’s Christopher Nolan epic The Odyssey is booked to have a three-week engagement in 70 mm when the pic opens on July 17. The 95-year-old ...

Spider-Man star Tom Holland says that Brand New Day was "almost saved" when he requested its production be delayed — so he could go shoot Christopher Nolan's The Odyssey first. Speaking to GQ, Holland ...

Tom Holland has a massive summer coming up with “Spider-Man: Brand New Day” and “The Odyssey” releasing two weeks apart. But, to make both happen, the actor had to convince Sony to move the entire ...

Travis Scott plays a bard in 'The Odyssey' and has been featured in various commercial spots for the movie, in theaters July 17 Tommy McArdle is a Writer-Reporter on the Movies team at PEOPLE. He ...

Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning. The autoimmune- and inflammatory-disease-focused company first ...